Rising health care costs and life-cycle management in the pharmaceutical market

PLoS Med. 2013;10(6):e1001461. doi: 10.1371/journal.pmed.1001461. Epub 2013 Jun 4.

Abstract

Aaron Kesselheim discusses Natalie Vernaz and colleagues' paper on the effects on health care costs of “evergreening” strategies pursued by drug manufacturers.

Please see later in the article for the Editors' Summary

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Comment

MeSH terms

  • Female
  • Health Care Costs*
  • Humans
  • Male
  • Nonprescription Drugs / economics*
  • Patents as Topic*

Substances

  • Nonprescription Drugs